Systematic Study of Ionic Liquids Based Coal Extraction: Selectivity in Extract Molecular Weights and Targeted Functional Groups

2020 ◽  
Vol 34 (4) ◽  
pp. 4554-4564
Author(s):  
Shuai Tan ◽  
Mitchell Ross Helling ◽  
Franco Basile ◽  
Katie Dongmei Li-Oakey
e-Polymers ◽  
2013 ◽  
Vol 13 (1) ◽  
Author(s):  
Jerzy Chruściel ◽  
Marzena Fejdyś ◽  
Witold Fortuniak

Abstract New liquid branched poly(methylvinylborosiloxanes) (br-PMVBS) of random structure were synthesized in three steps. By reacting boric acid with an excess of dimethyldichlorosilane (Me2SiCl2) in dry ether a “borosiloxane precursor”: tris(chlorodimethylsilyl) borate B(OSiMe2Cl)3 was prepared. In the second step of synthesis ether solution of B(OSiMe2Cl)3 was added to a mixture of appropriate organic chlorosilanes (Me2SiCl2, MeViSiCl2, MeSiCl3, and Me3SiCl) and all reagents were reacted with stoichiometric amounts of water, in the presence of pyridine (as an acceptor of HCl), in dry ether, at low temperature (usually at -10 to 0 C). In order to fully react (“to block”) trace silanol groups, reactions of intermediate PMVBS with additional batches of Me3SiCl were carried out in the third step, C5H5N·HCl was filtered off and washed with a dry ether. The solvent was distilled off from filtrates and low molecular weight siloxane oligomers were removed by a vacuum distillation at 130-150 C. Chemical structures of br-PMVBS were confirmed by elemental analysis and spectroscopic methods (FTIR, emission atomic spectroscopy ICP-AES, and NMR: 1H, 29Si and 11B). On the basis of analysis of their 29Si-NMR spectra the microstructure of polysiloxane chains was proposed. The prepared br-PMVBS had in their structures: triple branching borosiloxane units: BO1.5 and in some cases methylsiloxane moiety CH3SiO1.5 (T). They contained linkages: Si-O-Si, Si-O-B, vinyl(methyl)siloxane functional groups (CH2=CH)MeSiO (Dvi), dimethylsiloxane mers (CH3)2SiO (D), and non-reactive trimethylsiloxy terminal groups (CH3)3SiO0.5 (M), but they did not have: hydroxyl functional groups: Si-OH and B-OH, and sensitive to water B-O-B linkages. Molecular weights of br-PMVBS (Mn = 1500-3300 g/mol; Mw = 3800-7400 g/mol) and their polydispersity (Mw/Mn = 2.0-2.5) were determined by a size exclusion chromatography (SEC).


2014 ◽  
Vol 53 (17) ◽  
pp. 6871-6880 ◽  
Author(s):  
Da-Niu Cai ◽  
Kuan Huang ◽  
Yong-Le Chen ◽  
Xing-Bang Hu ◽  
You-Ting Wu

2012 ◽  
Vol 215-216 ◽  
pp. 40-48 ◽  
Author(s):  
Sylvie Viboud ◽  
Nicolas Papaiconomou ◽  
Aurélien Cortesi ◽  
Grégory Chatel ◽  
Micheline Draye ◽  
...  

2020 ◽  
Vol 11 (25) ◽  
pp. 6405-6422 ◽  
Author(s):  
Frederik Philippi ◽  
David Pugh ◽  
Daniel Rauber ◽  
Tom Welton ◽  
Patricia A. Hunt

Interchangeable functional groups for imide ions are investigated computationally, new ILs with low/high viscosity are designed a priori and experimentally characterised.


Fuel ◽  
2018 ◽  
Vol 212 ◽  
pp. 12-18 ◽  
Author(s):  
Özgür Sönmez ◽  
Özcan Yıldız ◽  
Mehmet Özden Çakır ◽  
Belgin Gözmen ◽  
E. Sultan Giray

2019 ◽  
Vol 19 (3) ◽  
pp. 171-179
Author(s):  
Saganuwan Alhaji Saganuwan

Background: Over fifty percent of drugs being used clinically are chiral and 90% of them are racemates. Unfortunately, they have both adverse and beneficial effects on body systems. Methods: Because of the erratic effects of chiral compounds on body functional systems, literature search was carried out with a view to identify CNS chiral drugs, their clinical advantages and disadvantages, unique physicochemical properties and structural modifications into safer drugs. Results: Findings have shown that majority of CNS and non-CNS acting drugs have chiral functional groups that may occur as either dextrorotatory (clockwise) or levorotatory (anticlockwise) or racemates which are inert. Sometimes, the enantiomers (optical isomers) could undergo keto-enol tautomerism, appearing in either acidic or basic or inert form. Chiral CNS acting drugs have agonistic and antagonistic effects, clinical advantages, disadvantages, and special clinical applications, possible modifications for better therapeutic effects and possible synthesis of more potent drugs from racemates. Clockwise chirality may be more effective and safer than the drugs with anticlockwise chirality. When chiral drugs are in racemate state they become inert and may be safer than when they are single. Also, diastereoisomers may be more dangerous than stereoisomers. Conclusion: Therefore, chiral compounds should be adequately studied in lab rodents and primates, and their mechanisms of actions should be comprehensively understood before being used in clinical setting. Since many of them are toxic, their use should be based on principle of individualized medicine. Their molecular weights, functional groups, metabolites, polymers and stereoisomers could be valuable tools for their modifications.


2015 ◽  
Vol 28 ◽  
pp. 394-399 ◽  
Author(s):  
Pablo Díaz-Rodríguez ◽  
John C. Cancilla ◽  
Gemma Matute ◽  
David Chicharro ◽  
José S. Torrecilla

2015 ◽  
Vol 54 (43) ◽  
pp. 10918-10924 ◽  
Author(s):  
Rafael Alcalde ◽  
Gregorio García ◽  
Mert Atilhan ◽  
Santiago Aparicio

Sign in / Sign up

Export Citation Format

Share Document